Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Oclaro, Inc. (Avanex-Bookham) -- Ignore unavailable to you. Want to Upgrade?

To: chuck weir who wrote (1540)	2/8/2001 10:44:59 PM
From: tinkershaw	Read Replies (1) \| Respond to of 2293

Time to get back in? What do you think? Is this whole sector going to tank big time next week...waiting for the earnings to show up...or are will the buy orders start showing up at 39 or 40? I think any of these prices are great come the end of the year should (and I expect it to) the economy start to recover big time by Q4. Indeed with a 5 yr CAGR of 60-100% growth for this sector projected, it is tough to go wrong. Still, I took advantage of the NTAP slaughter today. I traded out some AVNX around $52 a few days ago and moved the money into NTAP today at $35. It was just a much more slaughtered, pitiful stock. But I've given up predicting the market. Shell shock is my name. I'm just sticking with the best names, and the greatest points of capitulation and going for it. Seems to be working. The long-term valuations in many of these names leave me drueling. AVNX is certainly not the cheapest among them, but its cheap enough as long as it lives up to its promise. Fundamentally, AVNX should not disappoint going forward. Even the most bearish telecom analysts are stating that telecoms will still need to invest in optical, even if all else gets dumped. Buy it in the $40s and $50s. Sell it in the $70 and $80s. Seems to be a bit of an exhibition sport currently. Tinker P.S. Remember that the day AVNX hit $39 it was an abberational occurence based, most likely on mixing AVNX up with a drug of a similar name. So I wouldn't count on $39 as being in the trading range.